CIK 0001991792
- Large accelerated filer
CG Oncology, Inc.
Sign in to watch- Ticker
- CGON
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 371611499
- Phone
- +1 949-409-3700
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
- 4 Open-market buy Director bought 1,515,151 shares at $33.00 ($49,999,983)
- 4 Planned sale Director sold 27,015 shares at an average $31.53 ($851,797)
- 4 Planned sale Director sold 100,000 shares at an average $27.80 ($2,779,542)
- 4 Planned sale Director sold 1,000 shares at $28.00 ($28,000)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 2,000 shares at $28.00 ($56,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 1,000 shares at $28.00 ($28,000)
- 4 Planned sale Director sold 1,000 shares at $30.76 ($30,760)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 1,000 shares at $28.00 ($28,000)
Page 3 of 5 · 96 filings